Antihyperlipidemic and Histopathological Pancreas Analysis of Muntingia calabura L. Fruit Extract on Alloxan-Induced Diabetic Mice
-
Published:2023-10-31
Issue:
Volume:
Page:4841-4846
-
ISSN:0974-360X
-
Container-title:Research Journal of Pharmacy and Technology
-
language:en
-
Short-container-title:RJPT
Author:
Intan Solikhah Tridiganita1, Permata Solikhah Gahastanira2
Affiliation:
1. Division of Veterinary Clinic, Department of Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Indonesia. 2. Cahaya Petclinic, Veterinarian, Mojokerto, Indonesia.
Abstract
Hyperlipidemia is clinically manifested by high levels of Total Cholesterol (TC), Triglycerides (TG), Low Density Lipoprotein (LDL) and low levels of High Density Lipoprotein (HDL) in the blood. Antihyperlipidemic drugs available currently have adverse effects. One of the medicine plants with antihyperlipidemic properties with no side effects is Muntingia calabura fruit. The sample used for this research were 30 male mice were divided into 5 groups, i.e., a negative control, a diabetic control, a positive control group, and two treatment groups which were given 100 and 300mg/kg of M. calabura fruit extract every day for 14 days. Examination of TC, TG, HDL, LDL and histopathological pancreas were determined after administration of the extract orally for 14 days. The results demonstrated an administration of glibenclamide and M. calabura fruit could effectively reduce TC, TG and LDL and increase HDL compared to the diabetes control group (P<0.05). In the diabetes control group, the mice given alloxan 150mg/kg showed a decrease in Langerhans islet density, vascularity, and islet injury compared to the normal control group. Mice given M. calabura fruit extract showed a significant increase in pancreatic Langerhans cells granulation and cell density. The conclusion of this research is M. calabura fruit extract showed improvements in lipid profile and pancreatic Langerhans cell regeneration. Therefore, the fruit extract of M. calabura is a potential antihyperlipidemic drug.
Publisher
A and V Publications
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference40 articles.
1. Nwauche, Kelechi TG, Monago CC, Anacletus FC. Management of diabetic induced hyperlipidemia with combined therapy of reducdyn and metformin in streptozotocin induced diabetic male rats. Research Journal of Pharmacy and Technology. 2014; 7(8): 910-914. 2. Nwauche, Kelechi TG, Monago CC, Anacletus FC. Management of diabetic induced hyperlipidemia with combined therapy of reducdyn and metformin in streptozotocin induced diabetic male rats. Research Journal of Pharmacy and Technology. 2014; 7(9): 1041-1045. 3. Ning B, Chen Y, Waqar AB, Yan H, Shiomi M, Zhang J, Chen YE, Wang Y, Itabe H, Liang J, Fan J. Hypertension enhances advanced atherosclerosis and induces cardiac death in Watanabe heritable hyperlipidemic rabbits. The American Journal of Pathology. 2018; 188(12): 2936–47. doi: 10.1016/j.ajpath.2018.08.007. 4. Urvi S. Shah, K.N. Patel. Effects of Strychnos potatorum Linn. seeds on Triton WR 1339 Induced Hyperlipidemia in Rats. Research Journal of Pharmacy and Technology. 2012; 5(7): 901-904. 5. Zhao, H., Li, S., Zhang, J., Che, G., Zhou, M., Liu, M., Zhang, C., Xu, N., Lin, L., Liu, Y., & Jia, L. Acute hemodynamic effects of remote ischemic preconditioning on coronary perfusion pressure and coronary collateral blood flow in coronary heart disease. Acta Cardiologica Sinica. 2018; 34(4): 299–306. doi: 10.6515/ACS.201807_34(4).20180317A.
|
|